June 30, 2020
I was told last week about the mother of an acquaintance in Chicago. His mother has had Vertebral Fractures again and again and again. After each fracture she has been...
May 17, 2020
If you fracture, your risk of a second fracture within a year is 3 to 5 times as great! If that first or second fracture is a hip, you have...
March 2, 2020
Iowa Bone Club 2020 will meet at Allen College in Waterloo, IA on Friday 24 April. This is the only meeting in Iowa each year which is dedicated solely to...
December 8, 2019
National Bone Health treatment goals are changing for those patients with high fracture risk. Simply preserving bones already at a too high fracture risk never made much sense to this...
November 14, 2019
Recently I wrote about our participation in a clinical trial offering the anabolic Tymlos (Abaloparatide) to men. Now we have been approved for participation in another Tymlos (Abaloparatide) trial –...
September 3, 2019
FDA approved clinical trials are a well established way to gain access to medications not yet available to the general public. Most people have heard of individuals taking experimental treatments...
August 8, 2019
We now have a third anabolic medication to build new bone. Evenity is really different from the other anabolics, Forteo (teriparatide) and Tymlos (abaloparatide). Forteo and Tymlos are daily shots based...
February 27, 2018
Our goal is NO NEW FRACTURES. Therefore, Treat to Target means a FRAX score of <20% for “major osteoporotic” and <3% for hip fracture. Alternately, T-score of better than -1.5 if...
January 31, 2018
Treat to Target means aiming for NO NEW FRACTURES. As discussed last time, the original target was to maintain Bone Mineral Density (BMD) at the level first tested. 25 years...
September 24, 2017
The FDA approved Tymlos (Abaloparatide) in June for use in women diagnosed with osteoporosis. Unfortunately most patients are unlikely to obtain insurance coverage for Tymlos until January or February 2018. Tymlos...